🇺🇸 FDA
Pipeline program

SNS-101 (anti-VISTA)

SNS-101-2-1

Phase 2 small_molecule active

Quick answer

SNS-101 (anti-VISTA) for Solid Tumor, Adult is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Solid Tumor, Adult
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials